These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18086755)

  • 21. [Methylation of promoter region of RASSF1A gene and frequencies of allelic imbalances in chromosome 3 critical regions are correlated with progression of clear cell renal cell carcinoma].
    Loginov VI; Khodyrev DS; Pronina IV; Kazubskaia TP; Ermilova VD; Gar'kavtseva RF; Braga EA
    Mol Biol (Mosk); 2009; 43(3):429-38. PubMed ID: 19548529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
    Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
    Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [DNA methylation and histone modification relate to RASSF1A gene deletion in laryngeal carcinoma tissues].
    Yang J; Ji WY; Qu YR; He LX; Zhao XD; Jin MZ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Apr; 46(4):308-12. PubMed ID: 21624251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RASSF1A promoter methylation and 3p21.3 loss of heterozygosity are features of foregut, but not midgut and hindgut, malignant endocrine tumours.
    Pizzi S; Azzoni C; Bottarelli L; Campanini N; D'Adda T; Pasquali C; Rossi G; Rindi G; Bordi C
    J Pathol; 2005 Aug; 206(4):409-16. PubMed ID: 15887288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma.
    Seidel C; Schagdarsurengin U; Blümke K; Würl P; Pfeifer GP; Hauptmann S; Taubert H; Dammann R
    Mol Carcinog; 2007 Oct; 46(10):865-71. PubMed ID: 17538946
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
    Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
    BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
    Marsit CJ; Karagas MR; Danaee H; Liu M; Andrew A; Schned A; Nelson HH; Kelsey KT
    Carcinogenesis; 2006 Jan; 27(1):112-6. PubMed ID: 15987713
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
    Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
    Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
    Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
    Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
    Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
    Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of RASSF1A promoter methylation in operable breast cancer.
    Kioulafa M; Kaklamanis L; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Biochem; 2009 Jul; 42(10-11):970-5. PubMed ID: 19374895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aberrant methylation of RASSF4/AD037 in nasopharyngeal carcinoma.
    Chow LS; Lo KW; Kwong J; Wong AY; Huang DP
    Oncol Rep; 2004 Oct; 12(4):781-7. PubMed ID: 15375500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue.
    Yan PS; Venkataramu C; Ibrahim A; Liu JC; Shen RZ; Diaz NM; Centeno B; Weber F; Leu YW; Shapiro CL; Eng C; Yeatman TJ; Huang TH
    Clin Cancer Res; 2006 Nov; 12(22):6626-36. PubMed ID: 17121881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multigene methylation analysis of conventional renal cell carcinoma.
    Onay H; Pehlivan S; Koyuncuoglu M; Kirkali Z; Ozkinay F
    Urol Int; 2009; 83(1):107-12. PubMed ID: 19641369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer.
    Lee JJ; Geli J; Larsson C; Wallin G; Karimi M; Zedenius J; Höög A; Foukakis T
    Int J Oncol; 2008 Oct; 33(4):861-9. PubMed ID: 18813801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular profiling and classification of sporadic renal cell carcinoma by quantitative methylation analysis.
    Gonzalgo ML; Yegnasubramanian S; Yan G; Rogers CG; Nicol TL; Nelson WG; Pavlovich CP
    Clin Cancer Res; 2004 Nov; 10(21):7276-83. PubMed ID: 15534102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors.
    Sakamoto N; Terai T; Ajioka Y; Abe S; Kobayasi O; Hirai S; Hino O; Watanabe H; Sato N; Shimoda T; Fujii H
    Oncogene; 2004 Nov; 23(55):8900-7. PubMed ID: 15480433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.